Page 5 - Caredx News Today

Shares of CareDx, Inc (NASDAQ:CDNA – Free Report) have earned a consensus recommendation of “Hold” from the five ratings firms that are covering the company, MarketBeat reports. Four research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 1-year price objective among brokers […]

CareDx, Inc (NASDAQ:CDNA – Free Report) insider Reginald Seeto sold 2,818 shares of the business’s stock in a transaction that occurred on Monday, July 3rd. The shares were sold at an average price of $8.48, for a total value of $23,896.64. Following the completion of the sale, the insider now owns 498,055 shares of the […]

CareDx, Inc (NASDAQ:CDNA – Free Report) Director Peter Maag sold 2,432 shares of the business’s stock in a transaction on Wednesday, June 28th. The shares were sold at an average price of $8.72, for a total transaction of $21,207.04. Following the sale, the director now owns 313,136 shares of the company’s stock, valued at approximately […]

CareDx, Inc (NASDAQ:CDNA – Free Report) Director Peter Maag sold 2,432 shares of the stock in a transaction on Wednesday, June 28th. The stock was sold at an average price of $8.72, for a total value of $21,207.04. Following the completion of the sale, the director now directly owns 313,136 shares in the company, valued […]

CareDx, Inc (NASDAQ:CDNA – Free Report) insider Reginald Seeto sold 14,268 shares of the company’s stock in a transaction dated Wednesday, June 28th. The shares were sold at an average price of $8.76, for a total transaction of $124,987.68. Following the completion of the transaction, the insider now directly owns 500,873 shares in the company, […]

CareDx, Inc (NASDAQ:CDNA – Get Rating) insider Reginald Seeto sold 2,819 shares of the business’s stock in a transaction that occurred on Friday, June 2nd. The stock was sold at an average price of $8.13, for a total value of $22,918.47. Following the transaction, the insider now owns 532,177 shares in the company, valued at […]

Record Number of 65 Abstracts Showcasing CareDx Innovation Including Data Showing Clinical Utility of AlloSure Kidney to Guide Immunosuppression Management Experts Review Advancements in... | June 1, 2023

CareDx, Inc. , a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients... | June 1, 2023

CareDx, Inc (NASDAQ:CDNA – Get Rating) saw a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 6,200,000 shares, an increase of 19.2% from the April 30th total of 5,200,000 shares. Based on an average trading volume of 1,380,000 shares, the days-to-cover ratio is presently […]

Equities research analysts at StockNews.com began coverage on shares of CareDx (NASDAQ:CDNA – Get Rating) in a research note issued to investors on Thursday. The firm set a “hold” rating on the stock. A number of other equities research analysts have also recently commented on CDNA. The Goldman Sachs Group dropped their target price on […]